1017418

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 25, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)